Results 221 to 230 of about 5,582,484 (376)
Epigenetics of colorectal cancer: biomarker and therapeutic potential
G. Jung+4 more
semanticscholar +1 more source
Osteosarcoma isa highly aggressive bone cancer with an immunosuppressive tumor microenvironment that limits immunotherapy. This study explores STING pathway activation to reprogram tumor‐associated macrophages into a tumoricidal M1‐like phenotype and enhance doxorubicin efficacy. Results show that doxorubicin alone failed to activate the STING pathway,
Jordan C. O'Donoghue+3 more
wiley +1 more source
Adagrasib in the treatment of colorectal cancer. [PDF]
Haddad SF, Bouferraa Y, Nair KG.
europepmc +1 more source
Understanding miR‐200c: an Important Player in Resistance to Cancer Treatment
How can one microRNA alter cancer's response to therapy? miR‐200c plays a central role in therapeutic resistance by modulating epithelial‐mesenchymal transition, apoptosis, cancer stemness features, and drug efflux. This review outlines the context‐dependent functions of miR‐200c in various cancers and highlights its potential as both a biomarker and a
Fatma Sanli, Omer Faruk Karatas
wiley +1 more source
Immunohistochemical Cal9-9 in primary colonic polyps and polyps synchronous with colorectal cancer. [PDF]
Nezam H. Afdhal+4 more
openalex +1 more source
Lessons from Hereditary Colorectal Cancer
K. Kinzler, B. Vogelstein
semanticscholar +1 more source
Computational fluid dynamics analyses assess the upstream locomotion performance of anisotropic microrollers with varying height‐to‐width ratios. Observing their successful upstream locomotion in veins, their performance in hepatic circulation is investigated for treating primary liver cancer.
Burak Arslan+8 more
wiley +1 more source
Immunological detection of faecal occult blood in colorectal cancer
M Turunen+3 more
openalex +1 more source